Chivukula Pad

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
31
Insider Sells Sum
$11.91M

Insider Activity of Chivukula Pad

According to the SEC Form 4 filings, Chivukula Pad, being in a position of

  1. Chief Scientific Officer & COO at Arcturus Therapeutics Holdings Inc.,
    оver the last 12 months, has bought 0 shares, and sold 57114 shares for $2.05M,
    over all time since 2020-09-03, has bought 0 shares, and sold 285214 shares for $11.91M.

The largest sale of all time was on 2024-06-03 and amounted to 26000 shares of Arcturus Therapeutics Holdings Inc. for $1.04M.

Biography of Chivukula Pad

No biography is available at this moment.

2024-06-05SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
114
0.0004%
$45.00$5,130-51.07%
2024-06-03SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
26,000
0.095%
$40.01$1.04M-46.09%
2024-03-25SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
17,435
0.0652%
$35.02$610,574-23.65%
2024-03-19SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
8,565
0.033%
$35.01$299,839-20.9%
2023-11-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0187%
$18.72$93,602+53.89%
2023-10-02SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0188%
$25.61$128,062+6.78%
2023-09-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0187%
$31.45$157,264-9.92%
2023-08-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0184%
$34.91$174,550-13.4%
2023-07-14SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
25,000
0.093%
$35.01$875,250-12.53%
2023-07-03SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0189%
$28.75$143,750+8.03%
2023-06-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0189%
$27.16$135,800+10.95%
2023-05-11SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
7,925
0.0279%
$30.24$239,652-9.63%
2023-05-10SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
17,075
0.0656%
$30.00$512,250-0.37%
2023-05-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0187%
$25.93$129,650+12.25%
2023-04-03SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0186%
$25.38$126,900+11.48%
2023-03-06SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
5,000
0.0191%
$16.07$80,350+75.95%
2022-01-04SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
8,100
0.0319%
$40.00$324,000-52.6%
2021-12-16SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
3,633
0.0128%
$40.00$145,328-57.16%
2021-12-08SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
6,367
0.0246%
$40.00$254,680-52.82%
2021-11-01SaleArcturus Therapeutics Holdings Inc.
ARCT
Chief Scientific Officer & COO
10,000
0.0357%
$44.41$444,100-58.17%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.